Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A.O Smith | AOS | Nov 25, 2024 | 75.43 | +2.71 |
A10 Networks | ATEN | Nov 25, 2024 | 16.49 | -0.78 |
A2Z Cust2Mate Solutions | AZ | Nov 25, 2024 | 6.64 | -4.32 |
AA Mission Acquisition | AAM | Nov 25, 2024 | 10.05 | 0.00 |
AAA - A Rated Corporate Bond Ishares | QLTA | Nov 25, 2024 | 47.82 | +0.99 |
Aadi Bioscience | AADI | Nov 25, 2024 | 2.22 | -3.48 |
AAON | AAON | Nov 25, 2024 | 137.59 | +0.12 |
AAR | AIR | Nov 25, 2024 | 70.82 | +2.52 |
Abacus Life | ABL | Nov 25, 2024 | 7.67 | +1.59 |
Abbott Laboratories | ABT | Nov 25, 2024 | 118.13 | +0.31 |
AbbVie | ABBV | Nov 25, 2024 | 177.06 | +0.06 |
AbCellera Biologics | ABCL | Nov 25, 2024 | 2.95 | +6.88 |
Abeona Therapeutics | ABEO | Nov 25, 2024 | 5.94 | -0.67 |
Abercrombie & Fitch | ANF | Nov 25, 2024 | 154.50 | +1.65 |
Aberdeen Asia-Pacificome Fund | FAX | Nov 25, 2024 | 15.85 | +0.51 |
Aberdeen Australia Equity Fund | IAF | Nov 25, 2024 | 4.50 | -0.22 |
Aberdeen Emerging Markets Fund | AEF | Nov 25, 2024 | 5.23 | +0.38 |
Aberdeen Global Fund | FCO | Nov 25, 2024 | 5.94 | -1.49 |
Aberdeen Global Infrastructure | ASGI | Nov 25, 2024 | 19.65 | +0.49 |
Aberdeen Income Credit Strategies Fund | ACP | Nov 25, 2024 | 6.42 | 0.00 |
Aberdeen Income Credit Strategies Pref | ACP-A | Nov 25, 2024 | 24.00 | -0.21 |
Aberdeen Japan Equity Fund | JEQ | Nov 25, 2024 | 5.75 | +0.97 |
Abits Group | ABTS | Nov 25, 2024 | 0.66 | +5.24 |
Abivax SA - American Depositary Shares | ABVX | Nov 25, 2024 | 8.50 | -3.19 |
Able View Global | ABLV | Nov 25, 2024 | 0.88 | -2.22 |
ABM Industries | ABM | Nov 25, 2024 | 57.36 | +1.00 |
Above Food Ingredients | ABVE | Nov 25, 2024 | 0.81 | +26.40 |
Abpro Holdings | ABP | Nov 25, 2024 | 2.95 | 0.00 |
Abrdn Global Dynamic Dividend Fund | AGD | Nov 25, 2024 | 10.16 | +0.71 |
Abrdn Global Premier Properties Fund | AWP | Nov 25, 2024 | 4.30 | -0.92 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.